ArticleNeuroscience2011
GABA(B) restrains release from singly-evoked GABA terminals.
Article in Neuroscience, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Transcriptomic Profiling of Tetrodotoxin-Induced Neurotoxicity in Human Cerebral Organoids.Marine drugs · 2023Article
- Astrocytic glutamate transporters reduce the neuronal and physiological influence of metabotropic glutamate receptors in nucleus tractus solitarii.American journal of physiology. Regulatory, integrative and comparative physiology · 2020Article
- Endocannabinoids blunt the augmentation of synaptic transmission by serotonin 2A receptors in the nucleus tractus solitarii (nTS).Brain research · 2013Article
- Low-fidelity GABA transmission within a dense excitatory network of the solitary tract nucleus.The Journal of physiology · 2012Article
- 5-hydroxytryptamine 2C receptors tonically augment synaptic currents in the nucleus tractus solitarii.Journal of neurophysiology · 2012Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Neurotransmitter release regulation is highly heterogeneous across the brain. The fundamental units of release, individual boutons, are difficult to access and poorly understood. Here we directly activated single boutons on mechanically isolated nucleus tractus solitarius (NTS) neurons to record unitary synaptic events under voltage clamp. By scanning the cell surface with a stimulating pipette, we located unique sites that generated evoked excitatory postsynaptic currents (eEPSCs) or evoked inhibitory postsynaptic currents (eIPSCs) events. Stimulus-response relations had abrupt thresholds for all-or-none synaptic events consistent with unitary responses. Thus, irrespective of shock intensity, focal stimulation selectively evoked either eEPSCs or eIPSCs from single retained synaptic boutons and never recruited other synapses. Evoked EPSCs were rarely encountered. Our studies, thus, focused primarily on the more common GABA release. At most locations, shocks often failed to release GABA even at low frequencies (0.075 Hz), and eIPSCs succeeded only on average 2.7±0.7 successful IPSCs per 10 shocks. Activation of eIPSCs decreased spontaneous IPSCs in the same neurons. The GABA(A) receptor antagonist gabazine (3 μM) reversibly blocked eIPSCs as did tetrodotoxin (TTX) (300 nM). The initial low rate of successful eIPSCs decreased further in a use-dependent manner at 0.5 Hz stimulation-depressing 70% in 2 min. The selective GABA(B) receptor antagonist 3-[[(3,4-Dichlorophenyl)methyl]amino]propyl] diethoxymethyl)phosphinic acid (CGP 52432) (5 μM) had three actions: tripling the initial release rate, slowing the use-dependent decline without changing amplitudes, and blocking the shock-related decrease in spontaneous IPSCs. The results suggest strong, surprisingly long-lasting, negative feedback by GABA(B) receptors within single GABA terminals that determine release probability even in isolated terminals.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.